Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Compugen Ltd (NQ: CGEN)
14.74 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 4:26 PM EDT, Jul 1, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 14.74
Bid (Size) 13.68 (17)
Ask (Size) 15.17 (13)
Prev. Close 14.74
Today's Range 14.74 - 14.74
52wk Range 2.960 - 17.85
Shares Outstanding 45,822,807
Dividend Yield N/A
Performance
YTD
+140.85%
+140.85%
1 Month
-3.79%
-3.79%
3 Month
+111.48%
+111.48%
6 Month
+140.85%
+140.85%
1 Year
+298.38%
+298.38%
Top News
More News
Compugen Announces FDA Clearance of IND Application for Phase 1/2 Triple Combination Study of COM701 with Bristol Myers Squibb's Opdivo® (Nivolumab) and TIGIT Inhibitor
Study to evaluate simultaneous blockade of PVRIG, TIGIT and PD-1 immune checkpoints Read More
from PR Newswire
Compugen Doses First Patient in COM701 Phase 1 Monotherapy Expansion Cohort
Biomarker-informed strategy targets non-small cell lung, ovarian, breast, endometrial and colorectal cancers Read More
from PR Newswire
More News
Read More
Compugen Reports First Quarter 2020 Results
from PR Newswire
SCZ, KRNT, CGEN, RDWR: ETF Outflow Alert
category ETFs
from ETF Channel
Compugen Presents Data Update From Ongoing Phase 1 Trial of COM701 at the 2020 AACR Virtual Annual Meeting
from PR Newswire
Cramer Weighs In On Ciena, Harley-Davidson And More
category NVDA , CLX , ON , and 12 more.
from Benzinga
Analysts Predict 19% Gains Ahead For IBB
category ETFs
from ETF Channel
Interesting CGEN Put And Call Options For July 17th
category Stocks
from Market News Video
2 Top Biotech Picks for May
category VRTX , RHHBY , CGEN , and 1 more.
from Motley Fool
Allogene Jumps, Compugen Plunges Following Release Of Cancer Meeting Abstracts
category Stocks / Equities , Healthcare , Pharma/Biotech
from Blogs - TalkMarkets
Compugen sees "encouraging signals" from early-stage cancer trial
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.